CN Patent

CN108310442B — 眼科用组合物

Assigned to National Taipei University of Technology · Expires 2021-08-27 · 5y expired

What this patent protects

本发明揭示一种眼科用组合物，其包含0.5‑10％(w/v)的γ‑PGA及0.1x 10 ‑4 ‑2.0x10 ‑4 ％(v/v)的ClO 2 。该眼科用组合物可作为隐形眼镜保养液使用。

USPTO Abstract

本发明揭示一种眼科用组合物，其包含0.5‑10％(w/v)的γ‑PGA及0.1x 10 ‑4 ‑2.0x10 ‑4 ％(v/v)的ClO 2 。该眼科用组合物可作为隐形眼镜保养液使用。

Drugs covered by this patent

nicotine-polacrilex (NICOTINE POLACRILEX)

Patent Metadata

Patent number: CN108310442B
Jurisdiction: CN
Classification: —
Expires: 2021-08-27
Drug substance claim: No
Drug product claim: No
Assignee: National Taipei University of Technology
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.